Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
deals
life sciences
national blog main
alexion pharmaceuticals
biotech
boehringer ingelheim
clinical trials
eli lilly
san francisco blog main
san francisco top stories
alnylam pharmaceutials
amyotrophic lateral sclerosis (als)
arrowhead pharmaceuticals
autoimmune disorders
biontech
complement system
curevac
dicerna pharmaceuticals
fda
generalized myasthenia gravis
hepatitis b
immune-mediated necrotizing myopathy
indiana blog main
indiana top stories
infectious diseases
john shiver
johnson & johnson
moderna therapeutics
mrna
national top stories
neurodegenerative diseases
new york blog main
new york top stories
primary hyperoxaluria
ra pharmaceuticals
rare disease drugs
rna interference
What
deal
3
×
medicines
3
×
companies
pharma
rna
abandoning
ago
alternative
autoimmune
baggage
bets
bio
cancer
candidate
comes
cut
cuts
date
development
dicerna
disease
drug
effective
enticed
evidence
expensive
free
gets
hasn’t
interference
latest
lead
long
messenger
molecules
mrna
multiple
new
pharmaceutical
pharmaceuticals
Language
unset
Current search:
medicines
×
deal
×
boston
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines